The FDA has approved the updated Covid-19 vaccines for seniors and other people who are considered high-risk for severe outcomes. Hannah Beier/Reuters
As a group of advisers to the US Centers for Disease Control and Prevention meets to make recommendations on who should get the updated Covid-19 shot this season, a newly published analysis from dozens of researchers emphasizes the “substantial” benefits of broad vaccine recommendations.
The US Food and Drug Administration has already made significant changes to this season’s shots: limiting approval to adults 65 and older, and younger people who are at higher risk from Covid-19. The forthcoming vote from the CDC’s Advisory Committee on Immunization Practices, or ACIP, carries additional implications for vaccine access – and there ar